SCANDION ONC Aktie - Unternehmensdaten & Kurse - DK0061031895 | MoneyPeak

SCANDION ONC

Share · DK0061031895 · A2N9BV (XSTO)

No Price

n/a

Company Profile for SCANDION ONC Share

Scandion Oncology A/S, a clinical-stage biotechnology company, develops medicines for the treatment of chemotherapy resistance. Its lead product candidate includes the SCO-101, an oral compound that is in clinical Phase Ib and Phase II studies in cancer patients. The company's other product candidate is SCO-201, which is in preclinical trial for the treatment of solid tumors. Scandion Oncology A/S was founded in 2017 and is headquartered in Copenhagen, Denmark.

Get up to date insights from finAgent about SCANDION ONC

Company Data

Name SCANDION ONC

Company Scandion Oncology A/S

Website https://www.scandiononcology.com

Primary Exchange

NASDAQ STOCKHOLM AB

WKN A2N9BV

ISIN DK0061031895

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Francois Regis Martelet

Country Denmark

Currency EUR

Employees 0,0 T

Address Symbion, 2100 Copenhagen

IPO Date 2018-11-08

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	SCOL.ST
Frankfurt	8VY.F

More Shares

Investors who hold SCANDION ONC also have the following shares in their portfolio:

Daiki Axis Co., Ltd. Share

VOC ENERGY TRUST UNITS OF BENEFICIAL INTEREST Fund

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025